Acenocoumarol Market | Abbott, Alkaloida, Aurobindo
Acenocoumarol Market | Abbott, Alkaloida, Aurobindo
Source: pr-inside.com
Stay updated with breaking news from Systemic Embolism. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acenocoumarol Market | Abbott, Alkaloida, Aurobindo
Japan: A once-daily 15-mg dose of edoxaban may prevent stroke or systemic embolism in older Japanese patients with atrial fibrillation (AF) at high risk of bleeding, according to results of a...